Cite
MLA Citation
William Canovatchel et al.. “Efficacy of canagliflozin (CANA) versus dipeptidyl peptidase-4 inhibitors (DPP-4i) in patients with T2DM: Results from RCTs and Real-World (RW) study.” Diabetes research and clinical practice, vol. 120, n.d., pp. S118–. http://access.bl.uk/ark:/81055/vdc_100039989173.0x00003f